The present disclosure provides a new procedure for preparing a key intermediate for active pharmaceutical ingredients useful in the treatment of diseases related to the central nervous system.

The present disclosure provides a new procedure for preparing a key intermediate for active pharmaceutical ingredients useful in the treatment of diseases related to the central nervous system.

This invention is directed to, inter alia, compounds, methods, systems, and compositions for the maintenance, enhancement, and expansion of hematopoietic stem cells derived from one or more sources of CD34+ cells. Sources of CD34+ cells include bone marrow, cord blood, mobilized peripheral blood, and non-mobilized peripheral blood. Also provided herein are compounds of Formula I

##STR00001##

which are useful in maintaining, enhancing, and expanding of hematopoietic stem cells.

The invention is concerned with a method for producing a conjugated diene including a reaction step of subjecting a raw material gas containing a monoolefin having a carbon atom number of 4 or more to an oxidative dehydrogenation reaction with a gas containing molecular oxygen in the presence of a catalyst, to obtain a reaction product gas containing a conjugated diene; and a cooling step of cooling the reaction product gas, wherein in the cooling step, a cooling agent is supplied into a cooling column and brought into contact with the reaction product gas; the cooling agent discharged from the cooling column is then cooled by a heat exchanger; a precipitate dissolved in the cooling agent is precipitated within the heat exchanger and recovered; and the cooling agent from which the precipitate has been recovered is circulated into the cooling column.

The invention is concerned with a method for producing a conjugated diene including a reaction step of subjecting a raw material gas containing a monoolefin having a carbon atom number of 4 or more to an oxidative dehydrogenation reaction with a gas containing molecular oxygen in the presence of a catalyst, to obtain a reaction product gas containing a conjugated diene; and a cooling step of cooling the reaction product gas, wherein in the cooling step, a cooling agent is supplied into a cooling column and brought into contact with the reaction product gas; the cooling agent discharged from the cooling column is then cooled by a heat exchanger; a precipitate dissolved in the cooling agent is precipitated within the heat exchanger and recovered; and the cooling agent from which the precipitate has been recovered is circulated into the cooling column.

The invention relates to new types of modulators of the cold menthol receptor TRPM8, to methods of modulating the TRPM8 receptor using these modulators; and in particular the use of the modulators for inducing a sensation of coldness; and also the articles and compositions produced using these modulators.

The invention relates to new types of modulators of the cold menthol receptor TRPM8, to methods of modulating the TRPM8 receptor using these modulators; and in particular the use of the modulators for inducing a sensation of coldness; and also the articles and compositions produced using these modulators.

The present invention relates to processes of preparing N-((1,2,3,4,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)-1-iso-propyl-1H-pyrazole-3-sulfonamide and salts thereof. The present invention further relates to pharmaceutical compositions comprising such compounds and to the use of such compounds in the treatment and prevention of medical disorders and diseases, most especially by NLRP3 inhibition.

The present invention relates to processes of preparing N-((1,2,3,4,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)-1-iso-propyl-1H-pyrazole-3-sulfonamide and salts thereof. The present invention further relates to pharmaceutical compositions comprising such compounds and to the use of such compounds in the treatment and prevention of medical disorders and diseases, most especially by NLRP3 inhibition.

This invention is directed to, inter alia, compounds, methods, systems, and compositions for the maintenance, enhancement, and expansion of hematopoietic stem cells derived from one or more sources of CD34+ cells. Sources of CD34+ cells include bone marrow, cord blood, mobilized peripheral blood, and non-mobilized peripheral blood. Also provided herein are compounds of Formula I ##STR00001## which are useful in maintaining, enhancing, and expanding of hematopoietic stem cells.